The long pentraxin PTX3 in vascular pathology

被引:132
作者
Mantovani, Alberto
Garlanda, Cecilia
Bottazzi, Barbara
Peri, Giuseppe
Doni, Andrea
de la Torre, Yeny Martinez
Latini, Roberto
机构
[1] Ist Clin Humanitas, Res Lab Immunol & Inflammat, I-20089 Milan, Italy
[2] Univ Milan, Inst Gen Pathol, I-20133 Milan, Italy
[3] Mario Negri Inst Pharmacol Res, I-20157 Milan, Italy
关键词
pentraxin; PTX3; vascular pathology;
D O I
10.1016/j.vph.2006.08.011
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pentraxins are a family of evolutionarily conserved multifunctional pattern-recognition proteins characterized by a cyclic multimeric structure. Based on the primary structure of the subunit, the pentraxins are divided into two groups: short pentraxins and long pentraxins. C-reactive protein (CRP) and serum amyloid P-component (SAP) are the two short pentraxins. The prototype protein of the long pentraxin group is pentraxin 3 (PTX3). CRP and SAP are produced primarily in the liver in response to IL-6, while PTX3 is produced by a variety of tissues and cells and in particular by innate immunity cells in response to proinflammatory signals and Toll-like receptor (TLR) engagement. PTX3 interacts with several ligands, including growth factors, extracellular matrix components and selected pathogens, playing a role in complement activation and facilitating pathogen recognition by phagocytes, acting as a predecessor of antibodies. In addition, PTX3 is essential in female fertility by acting as a nodal point for the assembly of the cumulus oophorus hyaluronan-rich extracellular matrix. Thus, the prototypic long pentraxin PTX3 is a multifunctional soluble pattern recognition receptor acting as a non-redundant component of the Immoral arm of innate immunity and involved in tuning inflammation, in matrix deposition and female fertility. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:326 / 330
页数:5
相关论文
共 52 条
  • [21] Introna M, 1996, BLOOD, V87, P1862
  • [22] Complexity and complementarity of outer membrane protein a recognition by cellular and humoral innate immunity receptors
    Jeannin, P
    Bottazzi, B
    Sironi, M
    Doni, A
    Rusnatl, M
    Presta, M
    Maina, V
    Magistrelli, G
    Haeuw, JF
    Hoeffel, G
    Thieblemont, N
    Corvaia, N
    Garlanda, C
    Delneste, Y
    Mantovani, A
    [J]. IMMUNITY, 2005, 22 (05) : 551 - 560
  • [23] Biochemical interactions of the neuronal pentraxins - Neuronal pentraxin (NP) receptor binds to taipoxin and taipoxin-associated calcium-binding protein 49 via NP1 and NP2
    Kirkpatrick, LL
    Matzuk, MM
    Dodds, DC
    Perin, MS
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (23) : 17786 - 17792
  • [24] Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells
    Klouche, M
    Peri, G
    Knabbe, C
    Eckstein, HH
    Schmid, FX
    Schmitz, G
    Mantovani, A
    [J]. ATHEROSCLEROSIS, 2004, 175 (02) : 221 - 228
  • [25] Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction
    Latini, R
    Maggioni, AP
    Peri, G
    Gonzini, L
    Lucci, D
    Mocarelli, P
    Vago, L
    Pasqualini, F
    Signorini, S
    Soldateschi, D
    Tarli, L
    Schweiger, C
    Fresco, C
    Cecere, R
    Tognoni, G
    Mantovani, A
    [J]. CIRCULATION, 2004, 110 (16) : 2349 - 2354
  • [26] LEE GW, 1994, J IMMUNOL, V153, P3700
  • [27] LEE GW, 1993, J IMMUNOL, V150, P1804
  • [28] STRUCTURAL STUDIES ON C-REACTIVE PROTEIN
    LIU, TY
    ROBEY, FA
    WANG, CM
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1982, 389 (JUN) : 151 - 162
  • [29] Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA)
    Luchetti, MM
    Piccinini, G
    Mantovani, A
    Peri, G
    Matteucci, C
    Pomponio, G
    Fratini, M
    Fraticelli, P
    Sambo, P
    Di Loreto, C
    Doni, A
    Introna, M
    Gabrielli, A
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 119 (01) : 196 - 202
  • [30] Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity
    Mantovani, A
    Garlanda, C
    Bottazzi, B
    [J]. VACCINE, 2003, 21 : S43 - S47